Nitric oxide - ProStrakan

Alternative Names: S-291-N; TNO therapy - ProStrakan; Topical nitric oxide - ProStrakan

Latest Information Update: 26 Mar 2010

Price : ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator ProStrakan
Class Antiacnes; Antiandrogens; Antibacterials; Antifungals; Antihypertensives; Antivirals; Free radicals; Macromolecular substances; Nitrogen oxides; Non-opioid analgesics; Small molecules; Vasodilators
Mechanism of Action Nitric oxide donors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Human papillomavirus infections; Molluscum contagiosum; Onychomycosis

Most Recent Events

15 Mar 2016 Biomarkers information updated
08 Sep 2005 This compound is still in active development for Onychomycosis
22 Sep 2004 ProSkelia has merged with Strakan to form ProStrakan

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.